Sort
51,593 grants matching “hepatitis”
Molecular Mechanisms of Postnatal Islet alpha-cell Proliferation
$660,229Wenbiao Chen · Vanderbilt University · R01 · FY2021 · DK
Nutritional Status In HIV Hispanic Drug Abusers
$660,216Janet E Forrester · Tufts University Boston · R01 · FY2008 · DA
Role of the Omentum in the Treatment of Morbid Obesity
$660,196Naji N Abumrad · Vanderbilt University · R01 · FY2007 · DK
A 90 day, Phase 3, Open Labeled Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children with Short Bowel Syndrome who are Dependent on Parenteral Nutrition
$660,139Mark Puder · Boston Children'S Hospital · R01 · FY2021 · FD
Targeting System Xc- for the Treatment of Addiction
$660,133David A Baker · Marquette University · R01 · FY2010 · DA
Drug-gene-nutraceutical interactions of cannabidiol
$660,107Michael Thomas Eadon · Indiana University Indianapolis · R01 · FY2022 · AT
Antivirals directed to novel targets in the virus-coded proteinase of adenovirus
$659,944Walter F. Mangel · Brookhaven Science Assoc-Brookhaven Lab · R56 · FY2007 · AI
In pursuit of a one-stop shop: a hybrid type 1 effectiveness-implementation trial of comprehensive tele-harm reduction for people who inject drugs
$659,894Hansel Emory Tookes · University Of Miami School Of Medicine · R01 · FY2023 · DA
ITPR3 and aberrant mitochondrial calcium signaling in alcoholic hepatitis
$659,865Michael H Nathanson · Yale University · R01 · FY2025 · AA
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease
$659,801Christopher B Newgard · Duke University · R01 · FY2021 · DK
Behavioral Science and Biostatistics Resource Core for Alcohol-HIV Research
$659,716Christopher W. Kahler · Brown University · U24 · FY2017 · AA
Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma
$659,686Yazhen Zhu · University Of California Los Angeles · R01 · FY2021 · CA
Ex-vivo bioengineered technology to unravel dysfunction due to non-alcoholic steatohepatitis (NASH)
$659,671Jason A Wertheim · University Of Arizona · R01 · FY2024 · DK
Role of RNA modification in innate immune cell development and function
$659,663Shoubao Ma · Beckman Research Institute/City Of Hope · R01 · FY2025 · AI
Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention
$659,652Brian R. Edlin · National Development And Research Institutes, Inc. · R01 · FY2013 · DA
Defining the targets of broad intervention antimalarial agents
$659,642Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2014 · AI
Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth
$659,559Shannon Gwin Mitchell · Friends Research Institute, Inc. · R01 · FY2013 · DA
Confounder-Corrected Quantitative MRI Biomarkers of Hepatic
$659,522Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2015 · DK
Phase II trial of tesamorelin for cognition in aging HIV-infected persons
$659,438Ronald J. Ellis · University Of California, San Diego · R01 · FY2015 · AG
Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention
$659,430Shirish S Barve · University Of Louisville · R01 · FY2025 · AA
Conserved Fetal Epigenomic and Metagenomic Signatures in a Primate Model of Maternal Obesity
$659,426Kjersti Marie Aagaard-Tillery · Baylor College Of Medicine · R01 · FY2018 · DK
Novel aspects of Gdf15 biology and function
$659,199Michael J. Jurczak · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Development and Validation of Prognostic Radiomic Markers of Response and Recurrence for Patients with Colorectal Liver Metastases
$659,173Richard Kinh Gian Do · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration
$659,117Glenn Yiu · University Of California At Davis · R01 · FY2024 · EY
In Vivo And In Vitro Studies Of Hepatitis E Virus
$659,080Suzanne U Emerson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI